Andrew Ho

Biologics are increasingly utilized in COPD patients with T2 inflammation. Our study in BMC Pulmonary explores their impact on reducing systemic glucocorticoid burden bmcpulmmed.biomedcentral.com/articles/10.11… @BMC_series @BioMedCentral @TemplePCCM @TempleLung

🎉 Huge congratulations to the incredible graduates of the PCCM Class of 2025! You’ve worked so hard, grown so much, and we can’t wait to see all the amazing things you’ll do next!🌟 @JayyyyDr @DhananiZehra @DrMikeNicks @Tru_Ho @JensenGalvis @mbittner91 @MikeGouletDO

Proud of our fellows representing Temple PCCM at #ISHLT2025! @DhananiZehra @Tru_Ho @DrMikeNicks Their work in lung transplant research continues to push the field forward. Grateful to our faculty mentors for their support and guidance. @fatimaanjum28 @TempleHealth @ISHLT

So excited to present this wonderful class of board-certified pulmonologists 🥳🎉 Seen here in the first week of fellowship to now being board-certified, we couldn’t be more proud! @JayyyyDr @DhananiZehra @DrMikeNicks @Tru_Ho @JensenGalvis @mbittner91 @MikeGouletDO

Exploring the impact of comorbidities on patients with PE in Pulmonary Circulation - Analysis of a national database of 561k patients showed up to 5.4 fold increase in mortality in high comorbidity groups doi.org/10.1002/pul2.7… @ParthRali @PVRI @PulmCirc @TemplePCCM

Check out one of our second year fellows, Andrew Ho, in a video interview about his research presented at CHEST! ajmc.com/view/dr-andrew… #MedTwitter #PCCMTwitter #templemade

🗨️#CHEST2023: "It was impactful to see the degree by which #mortality climbs with increasing #comorbidities in a large population [of adults hospitalized with #PE] reflective of the entire United States,” Andrew Ho, MD, at @TempleHealth, told Healio. bit.ly/45sDMLZ